Roche Holding AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RHHBY research report →
About the company
Roche Holding AG functions as a major global healthcare enterprise, primarily concentrating its efforts within the pharmaceutical and diagnostic sectors. The company boasts an extensive international presence, with key operations located in countries such as Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, and Belgium. Its pharmaceutical division is dedicated to creating and supplying a diverse array of therapeutic remedies.
- CEO
- Thomas Schinecker
- IPO
- 2003
- Employees
- 103,249
- HQ
- Basel, CH
Price Chart
- Market Cap
- $341.62B
- P/E
- 21.05
- P/S
- 4.41
- P/B
- 8.02
- EV/EBITDA
- 13.18
- Div Yield
- 2.88%
- Gross Margin
- 73.53%
- Op Margin
- 31.32%
- Net Margin
- 20.94%
- ROE
- 41.23%
- ROIC
- 20.28%
- Revenue
- $63.36B · 1.54%
- Net Income
- $12.88B · 55.61%
- EPS
- $2.02 · 55.53%
- Op Income
- $18.48B
- FCF YoY
- -10.85%
- 52W High
- $60.85
- 52W Low
- $37.51
- 50D MA
- $51.22
- 200D MA
- $50.11
- Beta
- 0.34
- Avg Volume
- 2.10M
Get TickerSpark's AI analysis on RHHBY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our RHHBY coverage
Recent articles, reports, and earnings notes.
No research on RHHBY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RHHBY report →Similar companies
Peers in the same neighborhood.